Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 48: 577-579, 2002;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Feki, M.
Right arrow Articles by Mebazaa, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feki, M.
Right arrow Articles by Mebazaa, A.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Nutrition
(Clinical Chemistry. 2002;48:577-579.)
© 2002 American Association for Clinical Chemistry, Inc.

Technical Briefs

Serum Vitamin E and Lipid-adjusted Vitamin E Assessment in Friedreich Ataxia Phenotype Patients and Unaffected Family Members

Moncef Feki1, Samir Belal2, Habib Feki3, Malek Souissi1, Mahbouba Frih-Ayed4, Naziha Kaabachi1, Fayçal Hentati2, Mongi Ben Hamida2 and Abderraouf Mebazaa1a

1 Laboratory of Biochemistry, Rabta Hospital, 1007 Tunis, Tunisia

2 Service of Neurology, National Institute of Neurology, 1007 Tunis, Tunisia

3 Service of Community Medicine and Epidemiology, Hedi Chaker Hospital, 3029 Sfax, Tunisia

4 Service of Neurology, Fattouma Bourguiba Hospital, 5000 Monastir, Tunisia

aaddress correspondence to this author at: Laboratoire de Biochimie Clinique, Hôpital La Rabta, 1007 Eljabbari, Tunis, Tunisia; fax 216-71-570-506, e-mail abderraouf.mebazaa@rns.tn

Friedreich ataxia (FA) is an autosomal recessive spinocerebellar syndrome with onset before age 25, characterized by progressive cerebellar ataxia, dysarthria, areflexia, sensory loss in lower limbs, pyramidal weakness, and Babinski signs (1). It is caused by an intronic expanded unstable GAA repeat in the frataxin gene (2) located on chromosome 9q13-q21 (3). Investigating five Tunisian families with typical FA phenotype, Ben Hamida et al. (4) had excluded linkage to the locus of FA in two families and provided evidence for genetic heterogeneity of the disease. Patients belonging to families not linked to the locus of FA showed very low serum vitamin E (VE) with no evidence of lipid malabsorption.

The role of VE in maintaining human nervous system function is established, and the role of VE deficiency in neurologic disorders of a-ß-lipoproteinemia and biliary atresia is well accepted (5)(6). Several reports (4)(7)(8)(9)(10) have described patients with a progressive spinocerebellar syndrome associated with very low serum VE in the absence of fat malabsorption or a-ß-lipoproteinemia. This disease, termed ataxia with VE deficiency (AVED), is inherited with an autosomal recessive pattern (3)(4). The abnormal gene was mapped to chromosome 8q (11) and identified as the gene encoding for {alpha}-tocopherol transfer protein ({alpha}-TTP) (12).

Because it is difficult to distinguish on the basis of clinical features between AVED patients in whom VE supplementation may be beneficial (7)(13)(14) and those with classic FA, we assessed serum VE, total cholesterol . . . [Full Text of this Article]


Acknowledgments


References






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Association for Clinical Chemistry.